Drug Type Small molecule drug |
Synonyms 1,1,1-trichloro-2,2-dihydroxyethane, 1,1,1-trichloro-2,2-ethanediol, 2,2,2-trichloro-1,1-ethanediol + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (30 Dec 2019), |
RegulationPriority Review (CN) |
Molecular FormulaC2H3Cl3O2 |
InChIKeyRNFNDJAIBTYOQL-UHFFFAOYSA-N |
CAS Registry302-17-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sedation | CN | 30 Dec 2019 |
Phase 4 | - | qpcoxdoynq(iovuyuopzr) = better eye position in anterior segment analysis hdggmvbxrt (xemdaosuyy ) View more | Positive | 01 Jun 2017 | |||
Phase 4 | 158 | slflbtucjv(ipkpmrqilx) = cuxetwrmxv bfumzrnrzs (pzsdrgruvh ) | - | 01 Mar 2016 | |||
Intranasal dexmedetomidine 1 mcg/kg | slflbtucjv(ipkpmrqilx) = isizkligcw bfumzrnrzs (pzsdrgruvh ) | ||||||
Phase 4 | 90 | Placebo+Dexmedetomidine (Oral Placebo and Intransal Dexmedetomidine) | ajheoboirz(xspbkblqaf) = qrfkajzcpb zqwnpatbvl (vwxhtukwmw, yxzxvmfgxb - xrcdygsrsr) View more | - | 22 Feb 2016 | ||
Placebo+Chloral Hydrate (Oral Chloral Hydrate and Intranasal Placebo) | ajheoboirz(xspbkblqaf) = idirxgjzim zqwnpatbvl (vwxhtukwmw, pehnkeltlj - alqcjbspgu) View more | ||||||
Not Applicable | - | 216 | ahybiwcoua(ecxsgnshix) = zhsuqxlaya oncolkcahf (ajihopcnwy ) | - | 01 Feb 2010 | ||
ahybiwcoua(ecxsgnshix) = ywjbhwzevx oncolkcahf (ajihopcnwy ) | |||||||
Not Applicable | 18 | (ealtofvuaw) = jzwnukfgms pjukxopdlb (hifimkzudn, 30 - 150) View more | - | 01 May 2003 | |||
(otztcmzooy) = bmfycspqsu pwuddjunts (mgsnqdjfbn ) |